1FLT image
Deposition Date 1997-11-20
Release Date 1999-01-13
Last Version Date 2024-10-30
Entry Detail
PDB ID:
1FLT
Title:
VEGF IN COMPLEX WITH DOMAIN 2 OF THE FLT-1 RECEPTOR
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.70 Å
R-Value Free:
0.26
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:VASCULAR ENDOTHELIAL GROWTH FACTOR
Gene (Uniprot):VEGFA
Chain IDs:A (auth: V), B (auth: W)
Chain Length:98
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:FMS-LIKE TYROSINE KINASE 1
Gene (Uniprot):FLT1
Chain IDs:C (auth: X), D (auth: Y)
Chain Length:95
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation
Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor.
Cell(Cambridge,Mass.) 91 695 704 (1997)
PMID: 9393862 DOI: 10.1016/S0092-8674(00)80456-0

Abstact

Vascular endothelial growth factor (VEGF) is a homodimeric hormone that induces proliferation of endothelial cells through binding to the kinase domain receptor and the Fms-like tyrosine kinase receptor (Flt-1), the extracellular portions of which consist of seven immunoglobulin domains. We show that the second and third domains of Flt-1 are necessary and sufficient for binding VEGF with near-native affinity, and that domain 2 alone binds only 60-fold less tightly than wild-type. The crystal structure of the complex between VEGF and the second domain of Flt-1 shows domain 2 in a predominantly hydrophobic interaction with the "poles" of the VEGF dimer. Based on this structure and on mutational data, we present a model of VEGF bound to the first four domains of Flt-1.

Legend

Protein

Chemical

Disease

Primary Citation of related structures